News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sprague John M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 1,545 shares
@ $0.65, valued at
$1k
Sold 1,148 shares
@ $0.59, valued at
$677.3
Exercised 4,000 restricted stock units
@ $0
Exercised 2,914 restricted stock units
@ $0 |
|
| 04/11/2022 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Bought 10,000 shares
@ $0.4767, valued at
$4.8k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 437,158 restricted stock units
@ $0 |
|
| 02/23/2021 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 5,250 shares
@ $2.04, valued at
$10.7k
Exercised 10,000 restricted stock units
@ $0 |
|
| 03/03/2020 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 4,166 shares
@ $0.82, valued at
$3.4k
Exercised 10,000 restricted stock units
@ $0 |
|
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 60,000 options to buy
@ $3.72, valued at
$223.2k
Granted 30,000 restricted stock units
@ $0 |
|
| 07/24/2018 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Paid exercise price by delivering 5,619 shares
@ $6.72, valued at
$37.8k
|
|
| 06/29/2018 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 17,292 shares
@ $0 |
|
| 03/19/2018 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 69,170 options to buy
@ $0 |
|
| 03/02/2018 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 225,000 options to buy
@ $5.08, valued at
$1.1M
|
|
|
|